Oncology Drug Approval, Codevelopment, Biomarkers, In-Vitro Companion Diagnostics, Targeted Therapy Development, CDx Commercialization, Clinical Trial Services, Assay Development, Test Menu, Kits MolecularMD

MolecularMD accelerates oncology drug approval with targeted therapy development and commercialization bridging the gap between biomarkers and in-vitro CDx.

OVERVIEW

This domain molecularmd.com presently has a traffic ranking of zero (the smaller the better). We have scanned eighteen pages within the web site molecularmd.com and found twenty-one websites referencing molecularmd.com. We have acquired two contacts and addresses for molecularmd.com to help you communicate with them. This domain molecularmd.com has been online for nine hundred and eighty-one weeks, twenty days, sixteen hours, and eleven minutes.
Pages Crawled
18
Links to this site
21
Contacts
2
Locations
2
Online Since
Nov 2005

MOLECULARMD.COM RANKINGS

This domain molecularmd.com is seeing a alternation quantities of traffic all round the year.
Traffic for molecularmd.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for molecularmd.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for molecularmd.com

Date Range

All time
This Year
Last Year
Last Month

MOLECULARMD.COM HISTORY

This domain molecularmd.com was first documented on November 02, 2005. It was updated on November 04, 2013. It will go back on the market on November 02, 2018. As of today, it is nine hundred and eighty-one weeks, twenty days, sixteen hours, and eleven minutes young.
REGISTERED
November
2005
UPDATED
November
2013
EXPIRED
November
2018

SITE PERIOD OF EXISTANCE

18
YEARS
9
MONTHS
21
DAYS

LINKS TO WEB SITE

Biomarkers Immuno-Oncology World Congress 2018 - Cambridge Healthtech Institute

About the Biomarkers and Immuno-Oncology World Congress. Biomarkers and Immuno-Oncology World Congress. Now in Boston, is our longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. Predictive Biomarkers and Companion Diagnostics.

Clearwell Group

A Family office investment Advisory Firm. Building a lasting legacy of significance and stewardship. We facilitate strong family culture through investment management, estate planning, philanthropic advisory and family business consulting. Clearwell Group invests in public securities and private businesses. Read our Approach to Investing. View Our Criteria and Investments. A Family Office Investment Advisory Firm.

Bienvenido a DiagnosMed - DiagnosMed SRL

DIAGNOS MED SRL es una empresa Argentina fundada en 1989; especializada en la comercialización de reactivos para diagnóstico e investigación, representando en el país empresas líderes a nivel internacional. Las actividades incluyen la importación, distribución, asesoramiento técnico-científico y soporte promocional. Productos Diazyme para equipos de química clínica. Kits automatizables a múltiples instrumentos de química clínica.

Home Nextechinvest

We are a global investment advisor with a focus on oncology. Nextech is run by an experienced team of experts and supported by key opinion leaders in oncology. We deploy our expertise to invest equity in companies developing cancer therapeutics. PhD, Partner, Founder. PhD, Partner at Nextech Invest. Professor, Swiss Federal Institute of Technology Zurich.

Next Generation Dx Summit

Molecular Diagnostics for Infectious Disease. Microfluidics and Lab-on-a-Chip Devices for POCT. Clinical Application of Cell-Free DNA. Biomarkers for Cancer Immunotherapy and Combinations. Companion and Complementary Diagnostics in Immuno-Oncology. Sample Prep, Assay Development and Validation. Coverage and Reimbursement of Advanced Diagnostics.

Pyxis Communications - Pyxis Communications

Transform your life science marketing. Musings from the Pyxis ladies. See how we can help enhance your identity.

World CDx Boston 2015 Hanson Wade

Accelerating Targeted Drug Development to Market With High Value Companion Diagnostics. Annual World CDx Boston Summit continues to guide drug, diagnostic and technology developers all the way from early clinical development and translational biomarker validation to market launch of drug-CDx combinations. The World CDx Community will once again assemble to align drug-CDx co-development, showcase the most ground-breaking clinical trial results.

WHAT DOES MOLECULARMD.COM LOOK LIKE?

Desktop Screenshot of molecularmd.com Mobile Screenshot of molecularmd.com Tablet Screenshot of molecularmd.com

CONTACTS

Molecular MD

1341 SW Custer Drive

Portland, OR, 97219

US

MolecularMD

Goldade, Ryan

1341 SW Custer

Portland, OR, 97219

US

MOLECULARMD.COM HOST

We revealed that the main page on molecularmd.com took five hundred and thirty-one milliseconds to download. I could not find a SSL certificate, so we consider this site not secure.
Load time
0.531 secs
SSL
NOT SECURE
Internet Protocol
54.214.231.236

NAME SERVERS

ns6251.hostgator.com
ns6252.hostgator.com

BROWSER ICON

SERVER OS

I discovered that molecularmd.com is weilding the Apache/2.4.25 (Amazon) OpenSSL/1.0.1k-fips PHP/7.0.16 server.

PAGE TITLE

Oncology Drug Approval, Codevelopment, Biomarkers, In-Vitro Companion Diagnostics, Targeted Therapy Development, CDx Commercialization, Clinical Trial Services, Assay Development, Test Menu, Kits MolecularMD

DESCRIPTION

MolecularMD accelerates oncology drug approval with targeted therapy development and commercialization bridging the gap between biomarkers and in-vitro CDx.

CONTENT

This domain states the following, "Platforms, Applications Methods." We observed that the web site said " Bridging the gap between biomarkers and." It also stated " Companion Diagnostic solutions to accelerate targeted therapy development and commercialization. Platforms, Applications Methods. Leave this field empty if youre human." The header had MolecularMD as the highest ranking keyword. It was followed by molecular diagnostics and cancer therapies which isn't as ranked as highly as MolecularMD.

SEEK MORE BUSINESSES

Molecular Media Great Events Start Right Here

Working within the guidelines of your budget, Molecular Media can provide simple solutions to make your event unique and ensure each audience member is feeling your message from the moment they enter the venue. From custom logo presentations, to carefully planned lighting and sound effects, the details make the difference. Let us know about your meetings.

University of Maryland, Baltimore

Choose the UMB website that you wish to visit. University of Maryland, Baltimore. Francis King Carey School of Law.

Molecular Medicine - Graduate School of Biomedical Sciences - University of Texas Health Science Center at San Antonio

U54 Center for Cancer Systems Biology. Our goal is to educate and train the next generation of graduate students who will change the face of biomedical research and invent new ways to treat and prevent human diseases. Molecular Medicine in the News. Uncovering clues in BRCA1 breast cancer gene. Dr Rong Li and his colleagues are changing the paradigm of how BRCA1 suppresses tumors.

Molecularmeeting

Register for the EMMD 2017. We look back at a succesful and inspiring 10. EMMD which took place from October 11 - 13, 2017. When the dates for EMMD 2019 are known, these will be published on this website asap. For a photo impression of the EMMD 2017, please click here.